Wockhardt Q2 FY24 consolidated loss lowers at Rs. 77 Cr
Wockhardt has reported total income of Rs. 777 crores during the period ended September 30, 2023
Wockhardt has reported total income of Rs. 777 crores during the period ended September 30, 2023
Natco Pharma has reported total income of Rs. 1060.8 crores during the period ended September 30, 2023
Solara Active Pharma Sciences has reported total income of Rs. 426.42 crores during the period ended September 30, 2023
Reports revenue growth of 9% to INR 882 crores in Q2 FY24
EBITDA for Q2 FY24 at Rs. 71.2 crore as compared to Rs. 79.9 crore QoQ
Likmez oral suspension is the first and only FDA-approved liquid option for patients with adherence hurdles such as dysphagia, difficulty swallowing
Phase 3 data expected in the second half of 2024
Expanded collaboration with Vanguard Renewables aims to significantly increase the productivity of US renewable natural gas generation
Narayana Hrudayalaya has reported total income of Rs. 1323.64 crores during the period ended September 30, 2023
The company has raised US$4.5 million in funding for its AI operating system
Subscribe To Our Newsletter & Stay Updated